Effect of estradiol and clomiphene citrate on Erk activation in breast cancer cells. (16th October 2014)

• Record Type: Journal Article
• Authors: Elloumi-Mseddi, Jihene; Jemel-Oualha, Ikram; Beji, Abdelhamid; Hakim, Bochra; Aifa, Sami
• Is Part Of: Journal of receptor and signal transduction research. Volume 35:Number 2(2015)
• Page Start: 202
• Page End: 206
• Publication Date: 2014-10-16
• Subjects: Apoptosis -- cell proliferation -- clomiphene citrate -- Erk activation -- estradiol; Cell receptors -- Periodicals; Cellular signal transduction -- Periodicals; 571.6
• DOI: 10.3109/10799893.2014.951895
• Languages: English
• ISSNs: 1079-9893

Abstract

Abstract: The mitogen-activated protein kinase (MAPK) signaling pathway plays key roles in the transmission of proliferative signals in normal and dysregulated cells. Nevertheless, some studies have shown that activation of the extracellular regulated kinases 1/2 (Erk1/2) is involved in apoptosis. In this study, we evaluate the effect of two fertilizing drugs, clomiphene citrate and estradiol, on the activation of Erk1/2 and the viability of two breast cancer cell lines, MCF-7 (hormone dependent) and BT20 (hormone independent).We show that both drugs induce Erk1/2 phosphorylation in MCF-7 and BT20 cells despite their opposite effect on cell viability. In fact, clomiphene citrate is significantly proapoptotic while estradiol promotes cell proliferation. The fact that phospho-Erk1/2 is a common element to both mechanisms suggests that specific factors deciding between proliferation and apoptosis must be operative downstream of this signaling pathway.